Benchmark lowered the firm’s price target on Marcus (MCS) to $22 from $25 and keeps a Buy rating on the shares. Cnsistent with industry-wide exhibition weakness, the firm expects a softer fiscal Q3 for Marcus, followed by a meaningful rebound in fiscal Q4 as the release slate strengthens, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCS:
- Marcus Corp: Positioned for Multiyear Recovery with Strong Film Slate and Strategic Fiscal Shift
- Marcus Corporation: Strong Market Position and Growth Potential with Strategic Investments and Resilient Performance
- Taylor Swift plans return to movie theaters, Hollywood Reporter says
- Marcus management to meet with Benchmark
- Marcus Appoints Paul A. Leff to Board